Pretreatment with pPolyHb attenuates H 2 O 2 -induced endothelial cell injury through inhibition of JNK/p38 MAPK pathway by upregulation of heme oxygenase-1
Source abstract
Abstract
Polymerized porcine hemoglobin (pPolyHb) exhibits a protective effect on ischemia/reperfusion of organ grafts. A series of experiments were performed to explore the underlying cytoprotective mechanisms of pPolyHb pretreatment on H2O2-induced cell death and apoptosis. The results showed that the pretreatment augmented heme oxygenase-1 (HO-1) expression, and at the same time, decreased the phosphorylation of JNK/p38 mitogen-activated protein kinase (MAPK) and intracellular ROS generation in H2O2-treated HUVECs. Moreover, the inhibition of HO-1 expression by tin porphyrin (SnPP) abolished the protective effects of pPolyHb, which suggested that the cytoprotective effect of pPolyHb involves upregulating HO-1 and subsequently decreasing the phosphorylation of the JNK and p38 MAPK and ROS generation.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Heme Oxygenase-1 and Carbon Monoxide · Hemoglobin structure and function · Organ Transplantation Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Al-Huseini LM · J Biol Chem · 2014 · 289 · 1644210.1074/jbc.M113.532069 ↗
2. Ashraf MI · Cell Commun Signal · 2014 · 12 · 610.1186/1478-811X-12-6 ↗
3. Brugger J · Microcirculation · 2010 · 17 · 504
4. Chang TMS · 200710.1142/6395 ↗
5. Chen SD · Free Radic Res · 2012 · 46 · 94010.3109/10715762.2012.674640 ↗
6. 10.1146/annurev.pharmtox.010909.10560010.1146/annurev.pharmtox.010909.105600 ↗
7. Gu W · Am J Emerg Med · 2014 · 32 · 102710.1016/j.ajem.2014.06.004 ↗
8. Guibert EE · Transfus Med Hemother · 2011 · 38 · 12510.1159/000327033 ↗
9. Huang H · Artif Cells Nanomed Biotechnol · 2014 · 42 · 28910.3109/21691401.2013.845571 ↗
10. Kohmoto J · Am J Transplant · 2007 · 7 · 227910.1111/j.1600-6143.2007.01940.x ↗
11. 10.1007/s00228-011-1193-210.1007/s00228-011-1193-2 ↗
12. Li LP · Chin Med J (Engl) · 2010 · 123 · 2128
13. Li T · Artif Cells Blood Substit Immobil Biotechnol · 2011 · 39 · 39210.3109/10731199.2011.611472 ↗
14. Li T · Artif Cells Blood Substit Immobil Biotechnol · 2012 · 40 · 39610.3109/10731199.2012.696062 ↗
15. Man W · J Cell Biochem · 2014 · 115 · 115910.1002/jcb.24761 ↗
16. Morse D · Free Radical Biol Med · 2009 · 47 · 110.1016/j.freeradbiomed.2009.04.007 ↗
17. Papadopoulos D · Arch Trauma Res · 2013 · 2 · 6310.5812/atr.12501 ↗
18. Parada E · J Pineal Res · 2014 · 56 · 20410.1111/jpi.12113 ↗
19. Ramalingam M · Free Radical Res · 2014 · 48 · 34710.3109/10715762.2013.869588 ↗
20. Rhee SG · J Am Soc Nephrol · 2003 · 14 · S21110.1097/01.ASN.0000077404.45564.7E ↗
21. 10.1089/ars.2010.373310.1089/ars.2010.3733 ↗
22. Silva G · J Immunol · 2006 · 177 · 189410.4049/jimmunol.177.3.1894 ↗
23. Topp S · J Surg Res · 2008 · 150 · 24310.1016/j.jss.2008.02.033 ↗
24. 10.1155/2012/52430810.1155/2012/524308 ↗
25. 10.1371/journal.pone.009883410.1371/journal.pone.0098834 ↗
26. Wu W · Artif Cells Blood Substit Immobil Biotechnol · 2011 · 39 · 310.3109/10731199.2010.494581 ↗
27. Xie Q · Mol Med Rep · 2014 · 10 · 114310.3892/mmr.2014.2283 ↗
28. 10.1172/JCI416510.1172/JCI4165 ↗
29. 10.3109/10731199.2011.55958410.3109/10731199.2011.559584 ↗
30. 10.3109/10731199.2011.63149910.3109/10731199.2011.631499 ↗